Structure and functions of Mer, an innate immune checkpoint.
Structure and functions of Mer, an innate immune checkpoint.
复制标题
DOI:
10.3389/fimmu.2023.1244170
复制
发表时间:
2023
影响因子:
7.3
通讯作者:
Zahid, Kashif Rafiq
中科院分区:
文献类型:
--
作者:
Ubil, Eric;Zahid, Kashif Rafiq
Immunotherapy is a promising therapeutic tool that promotes the elimination of cancerous cells by a patient’s own immune system. However, in the clinical setting, the number of cancer patients benefitting from immunotherapy is limited. Identification and targeting of other immune subsets, such as tumor-associated macrophages, and alternative immune checkpoints, like Mer, may further limit tumor progression and therapy resistance. In this review, we highlight the key roles of macrophage Mer signaling in immune suppression. We also summarize the role of pro-inflammatory (M1) and anti-inflammatory (M2) phenotypes in tumor onset and progression and how Mer structure and activation can be targeted therapeutically to alter activation state. Preclinical and clinical studies focusing on Mer kinase inhibition have demonstrated the potential of targeting this innate immune checkpoint, leading to improved anti-tumor responses and patient outcomes.
登录
查看更多内容
影响因子:
3.3
作者:
Caberoy, Nora B.;Alvarado, Gabriela;Li, Wei
通讯作者:
Li, Wei
DOI:
10.1158/1078-0432.ccr-16-1330
发表时间:
2017-03-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
DeRyckere D;Lee-Sherick AB;Huey MG;Hill AA;Tyner JW;Jacobsen KM;Page LS;Kirkpatrick GG;Eryildiz F;Montgomery SA;Zhang W;Wang X;Frye SV;Earp HS;Graham DK
通讯作者:
Graham DK
影响因子:
7.3
作者:
Belov AA;Mohammadi M
通讯作者:
Mohammadi M
影响因子:
28.5
作者:
Chen Y;Zhang S;Wang Q;Zhang X
通讯作者:
Zhang X
影响因子:
8
作者:
Chen, J;Carey, K;Godowski, PJ
通讯作者:
Godowski, PJ